KALV
KalVista Pharmaceuticals Inc.
$11.41
-$0.10(-0.83%)
31
Overall
40
Value
25
Tech
28
Quality
Market Cap
$551.71M
Volume
678.52K
52W Range
$7.30 - $17.28
Target Price
$31.67
Key Metrics Overview
| Market Cap | $551.71M | P/E Ratio | N/A |
| 52W High | $17.28 | 52W Low | $7.30 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -3.2% | 52W Position | 41.1% |
| Overall Score | 31 | Value Score | 40 |
| Quality Score | 28 | Technical Score | 25 |
Growth Analysis
| EPS Current Est | $-3.42 | EPS Next Est | $-2.28 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $11.41 | -0.8% | 678.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW